438. Deputy Paul Nicholas Gogarty asked the Minister for Health if she will sanction a HIQA Health Technology Assessment on the effectiveness and long term health benefits of continuous glucose monitoring (CGM) for people with other types of diabetes, such as type 2 diabetes, cystic fibrosis-related diabetes, type 3c diabetes and so on, using daily insulin injections (basal-bolus) to potentially expand access to CGM based on clinical need rather than a type of diabetes. [67684/26]

Summary

438. Deputy Paul Nicholas Gogarty asked the Minister for Health if she will sanction a HIQA Health Technology Assessment on the effectiveness and long term health benefits of continuous glucose monitoring (CGM) for people with other types of diabetes, such as type 2 diabetes, cystic fibrosis-related diabetes, type 3c diabetes and so on, using daily insulin injections (basal-bolus) to potentially expand access to CGM based on clinical need rather than a type of diabetes. [67684/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 24 September 2026

   Medical Aids and Appliances

   438. Deputy Paul Nicholas Gogarty asked the Minister for Health if she will sanction a HIQA Health Technology Assessment on the effectiveness and long term health benefits of continuous glucose monitoring (CGM) for people with other types of diabetes, such as type 2 diabetes, cystic fibrosis-related diabetes, type 3c diabetes and so on, using daily insulin injections (basal-bolus) to potentially expand access to CGM based on clinical need rather than a type of diabetes. [67684/26]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medical Aids and Appliances

  xml · EN · 24 September 2026

  ViewDownloadOpen at official source

Sponsors

• Paul Nicholas Gogarty · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.